Preventing the transmission of mitochondrial DNA disorders using prenatal or preimplantation genetic diagnosis

Annals of the New York Academy of Sciences

Volumn 1350, Issue 1, 2015, Pages 29-36

  Smeets, Hubert J M ^a,b,c   Sallevelt, Suzanne C E H ^a,b   Dreesen, Jos C F M ^a   de Die Smulders, Christine E M ^a,c   de Coo, Irenaeus F M ^d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

mtDNA disease; nuclear transfer; preimplantation genetic diagnosis; prenatal diagnosis

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; DISEASE TRANSMISSION; GENE TRANSFER; GENOME; GENOME EDITING; HUMAN; MITOCHONDRIAL DNA DISORDER; MUTATIONAL LOAD; NONHUMAN; NUCLEAR GENOME TRANSFER; OOCYTE DONATION; POINT MUTATION; PREIMPLANTATION GENETIC DIAGNOSIS; PROGENY; RECURRENCE RISK;

EID: 84940702971     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12866     Document Type: Article

References (45)

1. McFarland, R., R.W. Taylor & D.M. Turnbull. 2010. A neurological perspective on mitochondrial disease. Lancet Neurol. 9: 829–840.
2. Anderson, S., A.T. Bankier, B.G. Barrell, et al. 1981. Sequence and organization of the human mitochondrial genome. Nature 290: 457–465.
3. Reynier, P., P. May-Panloup, M.F. Chretien, et al. 2001. Mitochondrial DNA content affects the fertilizability of human oocytes. Mol. Hum. Reprod. 7: 425–429.
4. Hellebrekers, D.M., R. Wolfe, A.T. Hendrickx, et al. 2012. PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring. Hum. Reprod. Update 18: 341–349.
5. White, S.L., V.R. Collins, R. Wolfe, et al. 1999. Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993. Am. J. Hum. Genet. 65: 474–482.
6. Chinnery, P.F., N. Howell, R.N. Lightowlers, et al. 1997. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 120: 1713–1721.
7. Thorburn, D.R. & H.H. Dahl. 2001. Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options. Am. J. Med. Genet. 106: 102–114.
8. Jacobs, L.J., G. de Wert, J.P. Geraedts, et al. 2006. The transmission of OXPHOS disease and methods to prevent this. Hum. Reprod. Update 12: 119–136.
9. Poulton, J., M.R. Chiaratti, F.V. Meirelles, et al. 2010. Transmission of mitochondrial DNA diseases and ways to prevent them. PLoS Genet. 6: e1001066.
10. Blok, R.B., D.A. Gook, D.R. Thorburn, et al. 1997. Skewed segregation of the mtDNA nt 8993 (T>G) mutation in human oocytes. Am. J. Hum. Genet. 60: 1495–1501
11. Brown, D.T., D.C. Samuels, E.M. Michael, et al. 2001. Random genetic drift determines the level of mutant mtDNA in human primary oocytes. Am. J. Hum. Genet. 68: 533–536.
12. Monnot, S., N. Gigarel, D.C. Samuels, et al. 2011. Segregation of mtDNA throughout human embryofetal development: m.3243A>G as a model system. Hum. Mutat. 32: 116–125.
13. Sharpley, M.S., C., Marciniak, K. Eckel-Mahan, et al. 2012. Heteroplasmy of mouse mtDNA is genetically unstable and results in altered behavior and cognition. Cell 151: 333–343.
14. Chinnery, P.F., S. DiMauro, S. Shanske, et al. 2004. Risk of developing a mitochondrial DNA deletion disorder. Lancet 364: 592–596.
15. Elliott, H.R., D.C. Samuels, J.A. Eden, et al. 2008. Pathogenic mitochondrial DNA mutations are common in the general population. Am. J. Hum. Genet. 83: 254–260
16. Poulton, J. & D.M. Turnbull. 1999. 74th ENMC international workshop: mitochondrial diseases 19–20 November 1999, Naarden, the Netherlands. Neuromuscul. Disord. 10: 460–462.
17. Dahl, H.H., D.R. Thorburn & S.L. White. 2000. Towards reliable prenatal diagnosis of mtDNA point mutations: studies of nt8993 mutations in oocytes, fetal tissues, children and adults. Hum. Reprod. 15: 246–255.
18. Steffann, J., N. Gigarel, J. Corcos, et al. 2007. Stability of the m.8993T→G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndrome. J. Med. Genet. 44: 664–669.
19. Jacobs, L.J., I.F.M. deCoo, J.G. Nijland, et al. 2005. Transmission and prenatal diagnosis of the T9176C mitochondrial DNA mutation. Mol. Hum. Reprod. 11: 223–228.
20. Marchington, D.R., M. Scott-Brown, D.H. Barlow, et al. 2006. Mosaicism for mitochondrial DNA polymorphic variants in placenta has implications for the feasibility of prenatal diagnosis in mtDNA diseases. Eur. J. Hum. Genet. 14: 816–823.
21. Bouchet, C., J. Steffann, J. Corcos, et al. 2006. Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: contribution to understanding mitochondrial DNA segregation during human embryofetal development. J. Med. Genet. 43: 788–792.
22. Steffann, J., N. Frydman, N. Gigarel, et al. 2006. Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis. J. Med. Genet. 43: 244–247.
23. Thorburn, D.R., L. Wilton & S. Stock-Myer. 2009. Healthy baby girl born following pre-implantation genetic diagnosis for mitochondrial DNA m.8993T>G mutation. Mol. Genet. Metabol. 98: 5–6.
24. Gigarel, N., L. Hesters, D.C. Samuels, et al. 2011. Poor correlations in the levels of pathogenic mitochondrial DNA mutations in polar bodies versus oocytes and blastomeres in humans. Am. J. Hum. Genet. 88: 494–498.
25. Sallevelt, S.C., J.C. Dreesen, M. Drüsedau, et al. 2013. Preimplantation genetic diagnosis in mitochondrial DNA disorders: challenge and success. J. Med. Genet. 50: 125–132.
26. Heindryckx B., J. Neupane, M. Vandewoestyne, et al. 2014. Mutation-free baby born from a mitochondrial encephalopathy, lactic acidosis and stroke-like syndrome carrier after blastocyst trophectoderm preimplantation genetic diagnosis. Mitochondrion 18: 12–17.
27. Treff, N.R., J. Campos, X. Tao, et al. 2012. Blastocyst preimplantation genetic diagnosis (PGD) of a mitochondrial DNA disorder. Fertil. Steril. 98: 1236–1240
28. Mitalipov S., P. Amato, S. Parry, et al. 2014. Limitations of preimplantation genetic diagnosis for mitochondrial diseases. Cell Rep. 7: 935–937
29. Poulton, J. & A.L. Bredenoord. 2010. 174th ENMC international workshop: applying pre-implantation genetic diagnosis to mtDNA diseases: implications of scientific advances 19–21 March 2010, Naarden, The Netherlands. Neuromuscul. Disord. 20: 559–563.
30. Bredenoord, A.L., W. Dondorp, G. Pennings, et al. 2008. PGD to reduce reproductive risk: the case of mitochondrial DNA disorders. Hum. Reprod. 23: 2392–2401.
31. Bredenoord, A.L., W. Donderop, G. Pennings, et al. 2010. Avoiding transgenerational risks of mitochondrial DNA disorders: a morally acceptable reason for sex selection? Hum. Reprod. 25: 1354–1360.
32. Samuels, D.C., P. Wonnapinij & P.F. Chinnery. 2013. Preventing the transmission of pathogenic mitochondrial DNA mutations: can we achieve long-term benefits from germ-line gene transfer? Hum. Reprod. 28: 554–559
33. Craven, L., J.L. Elson, L. Irving, et al. 2011. Mitochondrial DNA disease: new options for prevention. Hum. Mol. Genet. 20: R168–R174.
34. Tachibana, M., M. Sparman, H. Sritanaudomchai, et al. 2009. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 461: 367–372.
35. Tachibana, M., P. Amato, M. Sparman, et al. 2013. Towards germline gene therapy of inherited mitochondrial diseases. Nature 493: 627–631.
36. Wang, T, H. Sha, D. Ji, et al. 2014. Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell 157: 1591–1604
37. Paull, D., V. Emmanuele, K.A. Weiss, et al. 2013. Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature 493: 632–637.
38. Craven, L., H.A. Tuppen, G.D. Greggains, et al. 2010. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 465: 82–85.
39. Poulton, J., 2012. Nuclear tranfers to prevent maternal transmission of mitochondrial DNA disease. Br. Med. J. 345: e6651–e6652.
40. Bredenoord, A.L. & P. Braude. 2010. Ethics of mitochondrial gene replacement: from bench to bedside. Br. Med. J. 341: c6021.
41. Human Fertilisation & Embryology Authority. 2011. Review of scientific methods to avoid mitochondrial disease. Accessed August 16, 2014. www.hfea.gov.uk/6372.html.
42. Nuffield Council on Bioethics. 2012. Novel techniques for the prevention of mitochondrial DNA disorders: an ethical review. Accessed February 2015. http://nuffieldbioethics.org/project/mitochondrial-dna-disorders/
43. Cree, L. & P. Loi. 2015. Mitochondrial replacement: from basic research to assisted reproductive technology portfolio tool—technicalities and possible risks. Mol. Hum. Reprod. 21: 3–10.
44. Reddy, P., A. Ocampa, K. Suzuki, et al. 2015. Selective elimination of mitochondrial mutations in the germline by genome editing. Cell 161: 459–469.
45. Jacobs, L., M. Gerards, P. Chinnery, et al. 2007. mtDNA point mutations are present at various levels of heteroplasmy in human oocytes. Mol. Hum. Reprod. 13: 149–154.